XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.4
SHAREHOLDERS' EQUITY (Tables)
3 Months Ended
Nov. 30, 2024
Equity [Abstract]  
Schedule of Shares Outstanding
Shares Outstanding

Shares of Company's common stock outstanding for the three months ended November 30, 2024 and 2023 were as follows:
Three Months Ended
(in thousands)November 30, 2024November 30, 2023
Common stock outstanding, beginning of period20,051 19,938 
Common stock issued during the period34 28 
Common stock outstanding, end of period20,085 19,966 
Share-based Payment Arrangement, Option, Activity
The following table summarizes information about stock options:
(in thousands, except per share and weighted-average amounts)
Activity for the three months ended November 30, 2024Number of
Options
Weighted-Average
Exercise Price
Per Share
Weighted-Average
Remaining
Contractual Life
Outstanding, August 31, 20241,906 $37.64 6.91 years
Granted347 33.29 
Exercised(37)13.97 
Canceled/Forfeited(59)44.03 
Outstanding, November 30, 20242,157 $37.17 7.22 years
Vested and Exercisable, November 30, 2024995 $33.91 5.45 years
Vested and Expected to Vest, November 30, 20242,104 $37.08 7.18 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the three months ended November 30, 2024 and for the fiscal year ended August 31, 2024:
(in thousands, except weighted-average amounts)Three Months Ended November 30, 2024Fiscal Year 2024
Estimated fair value of awards granted$6,057 $11,902 
Unvested forfeiture rate6.25 %5.53 %
Weighted-average grant price$33.29 $40.76 
Weighted-average market price$33.29 $40.76 
Weighted-average volatility46.98 %44.63 %
Weighted-average risk-free rate3.93 %4.77 %
Weighted-average dividend yield0.00 %0.59 %
Weighted-average expected life6.61 years6.59 years
Share-based Payment Arrangement, Option, Exercise Price Range
The exercise prices for the options outstanding at November 30, 2024, ranged from $6.85 to $66.14 per share, and the information relating to these options is as follows:
(in thousands except prices and weighted-average amounts)
Exercise Price Per ShareAwards OutstandingAwards Exercisable
LowHighQuantityWeighted -Average
Remaining
Contractual
Life
Weighted-Average
Exercise
Price
QuantityWeighted-Average
Remaining
Contractual
Life
Weighted-Average
Exercise
Price
$6.85 $9.77 109 1.24 years$9.71 109 1.24 years$9.71 
$9.78 $18.76 139 2.23 years$10.07 139 2.23 years$10.07 
$18.77 $33.40 505 8.17 years$31.02 142 4.35 years$25.32 
$33.41 $47.63 1,126 8.14 years$41.35 436 7.60 years$41.26 
$47.64 $66.14 278 6.56 years$55.67 169 6.15 years$57.31 
  2,157 7.22 years$37.17 995 5.45 years$33.91